Governance

Trial sponsor

University of Newcastle

50+
Completed Trials
200+
Participants

ROADMAP Trial coordinating sponsor is the University of Newcastle, NSW Australia with each participating country having a regional sponsor, regional coordinating centre and regional Trial Steering Committee (TSC) and working groups. The overarching coordinating centre is the University of Newcastle located at the Hunter Medical Research Institute (HMRI).

Global Trial Management Group (TMG)

Global Trial Management Group

Professor Joshua Davis
Chief Investigator

Professor Laurens Manning
Co-Chief Investigator

Dr Marline Squance
Global Clinical Trial Manager

Jessica Massie
Data Manager/Coordinator

Hanah Hart
Isolate Repository Coordinator

Sandy Isles
Administrative Assistant

Mia Di Virgilio
Clinical Trial Coordinator & Monitor (Australia)

Alana Di Giacomo
Clinical Trial Coordinator & Monitor (Australia)

Alexandra Mowday
Clinical Trial Project Manager
(New Zealand)

Georgia Fowler
Clinical Trial Coordinator
(New Zealand)


Global Trial Steering Committee (GTSC)

The GTSC is responsible for the overall decision making related to the trial including the strategic direction and operational structure of the trial including setting research questions, protocol and domain development, the inclusion of any trial related sub-studies, the research data analysis and final reporting of research findings including publication oversight.

The membership of the GTSC consists of lead representatives from infectious disease and orthopaedic surgical disciplines from each participating country, as well as experts in adaptive trials, statistics, microbiology, chairs of trial working groups, a consumer PJI expert and the Global project manager.

Data Safety and Monitoring Committee (DSMC)

The DSMC membership is independent of steering committees, working groups and any sponsor Institute of the trial. The DMSC has the role of monitoring the safety and efficacy of the trial including patient safety and quality control of data as well as recruitment and the application of trial specific adaptive platform rules which have been set at the commencement of the trial.  The DSMC, advise trial committees on all these areas of the trial.

The DSMC is composed of clinician and research members that are knowledgeable in the fields of prosthetic joint infections (PJI), surgical treatment of PJI, adaptive platform research trials, the pharmacological treatment of PJI, and research statistics.

We are currently working on finalising the membership of this group.
Data Safety and Management Committee
Chair:  

Roger Lewis

Members:

Nicolas Cortes-Penfield

Nicolas Piuzzi

Gerard Slobogean

Sandra Nelson

Regional Trial Steering Committees

Australia
Chair:  

Dr Paul Chapman

Members:
New Zealand - TBA
Co-Chairs:  
Members:

Dr Mei Lin Tay

Dr Christopher Luey

Dr Alexandra Mowday

Ms Georgia Fowler

Mr John Mutu-Grigg


Canada - TBA
Co-Chairs:  
Members

Dr Jennie Johnstone

Dr Marisa Ann Azad

Dr Terence Wuerz

Dr Peter Daley
Dr Adam Hart
Tracey MacCharles

Dr Jesse Wolfstadt
Dr Jason Werle

Dr James Howard
Dr Elissa Rennert-May

United Kingdom - TBA
Chair:  

TBA






Members:

TBA






Antibiotic Working Group

Antibiotic Working Group
1. Antibiotic Duration

Chair:
Members:

2. Antibiotic Choice

Co-Chairs:
Members:

Statistics Working Group

Statistics Working Group

Analytic Group

Analytic Group
Chair:

TBA






Members:

TBA






Health Economics Group

Health Economics Group
Chair:

Dr Victoria McCreanor

Members:

Consumer Reference Group

Consumer Reference Group
Chair:

Tracey Cotter








Members:

TBA






ABOUT

ROADMAP Team

ROADMAP is supported by a number of key personnel in a global trial management group (TMG) as well as a global trial steering committee (GTSC), regional trial management groups from each participating country, and ROADMAP specialist working groups. Together they all guide the study to meet its research goals with scientific validity, safety and with a focus on improving health outcomes for people that experience prosthetic joint infections.

Learn More
PJI investigators